Litigation
Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC
terminated1:18-cv-02032
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Court
- D. Del.
- Filed
- 2018-12-20
- Terminated
- 2022-02-09
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
D. Del. generic-vs-generic action listed on DrugPatentWatch's US 6,780,889 litigation page. The narrative flags this as a low-confidence attribution, possibly a database cross-listing artifact, and could not corroborate that US 6,780,889 was actually asserted.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).